Dermata Therapeutics, Inc.DRMANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank80
3Y CAGR-63.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-63.9%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 8.50% |
| 2023 | -1.28% |
| 2022 | -8.51% |
| 2021 | 181.04% |
| 2020 | -15.24% |
| 2019 | 0.00% |